Tamoxifen patent litigation
Executive Summary
AstraZeneca's Nolvadex patent was upheld at the district and appellate court levels in a decision against Novopharm in 1996. The Sept. 25 "The Pink Sheet" (p. 24) incorrectly identifies the generic firm